Cargando…
Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections
Objective: To analyze the availability and access to the hospital for the patients with intra-abdominal infections (IAIs) by Escherichia coli (E. coli) as a result of the coronavirus disease 2019 (COVID-19) pandemic and the impact of these changes in the diagnosis and their effects on the death of t...
Autores principales: | Gálvez-Benítez, Lydia, Rodríguez-Villodres, Ángel, Álvarez-Marín, Rocío, Jiménez-Rodríguez, Rosa, Lepe-Jiménez, José Antonio, Pachón, Jerónimo, Smani, Younes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563694/ https://www.ncbi.nlm.nih.gov/pubmed/34746164 http://dx.doi.org/10.3389/fmed.2021.687415 |
Ejemplares similares
-
Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli
por: Rodríguez-Villodres, Ángel, et al.
Publicado: (2021) -
Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections
por: Rodríguez-Villodres, Ángel, et al.
Publicado: (2019) -
Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test
por: Rodríguez Villodres, Angel, et al.
Publicado: (2022) -
In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2018) -
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)